Search
AtriCure Inc
ATRCAdd to Watchlist
28.800USD
+1.680+6.19%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.43BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of AtriCure Inc is 8.00, ranking 66 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 50.00, with a high of 64.00 and a low of 40.00.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
49.375
Target Price
+71.44%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
AtriCure Inc
ATRC
10
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is AtriCure Inc's expected revenue for the next quarter?
AtriCure Inc's expected revenue is 152.05M.
What is AtriCure Inc's price target?
Analysts forecast that AtriCure Inc's price target is USD 50.00, with the highest forecast at USD 64.00 and the lowest forecast at USD 40.00.
What is the analyst rating for AtriCure Inc?
Based on the ratings of AtriCure Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
